Quest Diagnostics Inc vs Essex Property Trust, Inc. — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Essex Property Trust, Inc. trades at $282.11 (market cap $18.15B). The key difference: Quest Diagnostics Inc is the larger of the two by market cap, and Essex Property Trust, Inc. pays the higher dividend (3.93%). Which is the better fit depends on your goals.
| DGX | ESS | |
|---|---|---|
Market Cap | $26.21B | $18.15B |
Sector | Health | Real Estate |
52-Week High | $238.50 | $298.33 |
52-Week Low | $173.49 | $239.61 |
Enterprise Value | $31.97B | $24.75B |
Dividend Yield | 1.45% | 3.93% |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →